注射用黄芪多糖治疗肿瘤的临床研究进展  

Research progress on treatment of tumor with Astragalus polysaccharides for injection

作　　者：张莹[1] 王蕾[2] 杜梦楠[2] 

机构地区：[1]天津中医药大学第一附属医院,天津300193 [2]天津中医药大学,天津300193

出　　处：《药物评价研究》2016年第6期1092-1094,共3页Drug Evaluation Research

基　　金：天津市高等学校科技发展基金计划项目(20110223);天津市应用基础及前沿技术研究计划(12JCQNJC07500)

摘　　要：注射用黄芪多糖是从黄芪中提取的阿拉伯半乳聚糖复合物,在肿瘤临床治疗中应用广泛。注射用黄芪多糖与化疗联用、与放疗联用起到"增效减毒"的作用,而且是一种肿瘤耐药逆转剂,与其他肿瘤辅助药物联合使用可以改善瘤患者生活质量。The injection of Astragalus polysaccharide is a kind of Arabia galactose complex extracted from Astragalus Linn. It is widely used in clinical treatment of cancer. When Astragalus polysaccharide is combined with chemotherapy or radiotherapy, it can increase efficiency and reduce toxicity. And it is also a kind of tumor drug resistance reversal agent. When it is used with other auxiliary drugs, it can improve the quality of life of tumor patients.

关 键 词：注射用黄芪多糖 肿瘤 增效减毒 耐药逆转 协同作用 

分 类 号：R979.1[医药卫生—药品]